Piramal Alternatives
Piramal Alternatives is the Mumbai-based alternative-asset and fund-management arm of the Piramal Group, deploying growth capital via vehicles such as India Credit Opportunities Fund II into Indian mid-market companies, with disclosed activity in the pharmaceutical sector.
- Company typePublic
- Founded-
- HeadquartersMumbai, India
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Piramal Alternatives does
Piramal Alternatives is the fiduciary alternative-asset and fund-management business of the Piramal Group, operating from Mumbai as a division of Piramal Enterprises Limited (a publicly listed Indian conglomerate with 100+ years of operating heritage). Its primary disclosed product is India Credit Opportunities Fund II, an alternative credit vehicle that deploys growth capital into Indian mid-market companies. The unit's stated investment thesis centers on providing funding for brand acquisitions, therapeutic expansion, and cross-border market entry — demonstrated by its April 2025 lead investment of approximately Rs 160 crore ($18.8 million) in Chennai-based pharmaceutical manufacturer Saimirra Innopharm, which produces over 275 products across 70 countries.
The business model is a fund-management economics structure: Piramal Alternatives raises and manages third-party (and group) capital through dedicated vehicles such as Fund II, earning management fees on committed/invested AUM and, over time, carried interest on realizations. Distribution and deal-flow leverage the wider Piramal Group ecosystem — including Piramal Finance (an NBFC operating in 13,000+ Indian pin codes), Piramal Pharma, and Piramal Realty — alongside the group's international presence in the UK and USA. Capital is sourced via the group's fiduciary infrastructure, and dedicated leadership (Kalpesh Kikani, Managing Director) sits separate from the parent NBFC's retail lending leadership under Anand Piramal. The unit's competitive positioning rests on the Piramal brand, regulatory and governance infrastructure of a listed parent, and the credit-underwriting capability proven through the landmark 2019 Rs 34,250 crore DHFL acquisition under IBC. No AI/ML capability, app, or public-facing technology stack is disclosed for Piramal Alternatives specifically.
Piramal Alternatives firmographics
Firmographics- Name
- Piramal Alternatives
- Legal name
- Piramal Enterprises Limited
- Website
- https://piramal.com
- Company type
- Public
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Piramal Alternatives is the Mumbai-based alternative-asset and fund-management arm of the Piramal Group, deploying growth capital via vehicles such as India Credit Opportunities Fund II into Indian mid-market companies, with disclosed activity in the pharmaceutical sector.
- Ownership category
- akta.pro rank
Piramal Alternatives industry classification
Industry- Product category
- Alternative Credit Asset Management
- NAICS
- Investment Banking and Securities Intermediation (523150), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Secondaries — Preferred Equity / Structured Secondary Solutions (FSAHALAL)
Keywords
Where Piramal Alternatives is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Piramal Alternatives business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Piramal Alternatives product offering
Product offeringCore offering
Piramal Alternatives is the fiduciary and fund management business of the Piramal Group, managing alternative credit investment vehicles such as the India Credit Opportunities Fund II. It deploys growth capital into Indian businesses, including targeted investments in sectors such as pharmaceuticals (e.g., Rs 160 crore investment in Saimirra Innopharm) to support brand acquisitions, therapy expansion, and international market growth.
Differentiator
Problem solved
Functional benefit
Products and services
- India Credit Opportunities Fund II An alternative credit investment fund managed by Piramal Alternatives that provides growth capital to Indian businesses. The fund deployed approximately Rs 160 crore ($18.8 million) into Chennai-based Saimirra Innopharm to support its brand acquisitions and expansion across therapies and markets.
Companies that use Piramal Alternatives
Customer profileSegments1 record
Ideal customer profiles1 record
Piramal Alternatives technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Piramal Alternatives partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Piramal Alternatives competitors and assessment
Company assessmentDirect peers
- KKR India: Global alternative asset manager with a large India presence across private equity and private credit. KKR competes with Piramal Alternatives for mid-market Indian credit and growth deals, particularly in healthcare and consumer.
- Blackstone India: World's largest alternative asset manager with active India private equity and credit strategies. Competes with Piramal Alternatives for structured capital and growth equity opportunities in Indian mid-market companies.
- Carlyle India: Global private equity firm with established India operations across multiple funds. Competes for similar mid-market growth and structured capital opportunities in India, including the healthcare and financial services sectors.
- Bain Capital India: Global alternative asset manager with India-focused PE and credit funds. Competes with Piramal Alternatives in mid-market Indian companies seeking growth capital and structured credit solutions.
- ChrysCapital: One of India's largest homegrown private equity firms, focused on growth and structured capital deals in Indian mid-market companies across healthcare, financial services, and consumer sectors.
- Warburg Pincus India: Global growth equity firm with active India operations. Competes with Piramal Alternatives for growth capital and structured equity investments in Indian mid-market companies, particularly in healthcare and financial services.
- ICICI Venture: India-based private equity and venture capital firm affiliated with ICICI Group. Competes with Piramal Alternatives in Indian mid-market growth and structured capital transactions across multiple sectors.
- Kotak Investment Advisors: Alternative asset management arm of Kotak Mahindra Group. Competes with Piramal Alternatives in Indian private credit, real estate, and infrastructure fund management with similar group-affiliated platform advantages.
- JM Financial: India-based financial services group with private credit, lending, and alternative investment businesses. Competes with Piramal Alternatives in structured credit and growth capital for Indian mid-market companies.
Regional players
- Avendus Capital: India-focused investment bank and alternative asset manager. Provides structured capital, private credit, and growth equity solutions to Indian mid-market companies, overlapping with Piramal Alternatives' deal universe.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Piramal Alternatives social profiles
Digital presencePiramal Alternatives financial estimates
Financial estimateRevenue estimate
Valuation estimate
Piramal Alternatives leadership team
Management profileNumber of profiles
Profiles1 record
Piramal Alternatives funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Piramal Alternatives M&A and investment
M&A and investmentM&A
Investments8 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Piramal Alternatives
What does Piramal Alternatives do?
Piramal Alternatives is the fiduciary and fund management business of the Piramal Group, managing alternative credit investment vehicles such as the India Credit Opportunities Fund II. It deploys growth capital into Indian businesses, including targeted investments in sectors such as pharmaceuticals (e.g., Rs 160 crore investment in Saimirra Innopharm) to support brand acquisitions, therapy expansion, and international market growth.
Is Piramal Alternatives a public or private company?
Piramal Alternatives is a public company. It is classified as public and is currently operating.
When was Piramal Alternatives founded?
Piramal Alternatives was founded in -1. It employs 101 to 250 people.
Where is Piramal Alternatives based?
Piramal Alternatives is headquartered in Mumbai, India, in the Asia region.
Who are Piramal Alternatives's main competitors?
Direct peers on record are KKR India, Blackstone India, Carlyle India, Bain Capital India, ChrysCapital, Warburg Pincus India, ICICI Venture, Kotak Investment Advisors and JM Financial. Avendus Capital is listed as a regional player.
Does Piramal Alternatives have an API?
No public API is recorded for Piramal Alternatives.
What industry is Piramal Alternatives in?
Piramal Alternatives's product category is Alternative Credit Asset Management. Its primary akta.pro industry code is FSAHALAL, Secondaries — Preferred Equity / Structured Secondary Solutions. Its NAICS code is 523150 and its SIC code is 6211.